Merck & Co Inc

NYSE:MRK   4:00:00 PM EDT
104.40
-1.14 (-1.08%)
5:43:29 PM EDT: $104.65 +0.25 (+0.24%)
Products

Merck Animal Health Receives U.S. FDA Approval Of Expanded Indication For Bravecto (Fluralaner) Chews For Dogs

Published: 01/26/2023 13:53 GMT
Merck & Co Inc (MRK) - Merck Animal Health Receives U.S. FDA Approval of Expanded Indication for Bravecto (fluralaner) Chews for Dogs.